Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

Similar articles for PubMed (Select 9257684)

1.

3-Methoxynaltrexone, a selective heroin/morphine-6beta-glucuronide antagonist.

Brown GP, Yang K, King MA, Rossi GC, Leventhal L, Chang A, Pasternak GW.

FEBS Lett. 1997 Jul 21;412(1):35-8.

2.

Antagonism of heroin and morphine self-administration in rats by the morphine-6beta-glucuronide antagonist 3-O-methylnaltrexone.

Walker JR, King M, Izzo E, Koob GF, Pasternak GW.

Eur J Pharmacol. 1999 Oct 27;383(2):115-9.

PMID:
10585524
3.

3-Methoxynaltrexone is not a selective antagonist for the acute psychomotor stimulating effects of heroin and 6-monoacetylmorphine in mice.

Eriksen GS, Andersen JM, Boix F, Mørland J.

Pharmacol Biochem Behav. 2014 Jul;122:82-8. doi: 10.1016/j.pbb.2014.03.018. Epub 2014 Mar 31.

PMID:
24699386
4.
5.

Morphine-6beta-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans.

van Dorp EL, Kest B, Kowalczyk WJ, Morariu AM, Waxman AR, Arout CA, Dahan A, Sarton EY.

Anesthesiology. 2009 Jun;110(6):1356-63. doi: 10.1097/ALN.0b013e3181a105de.

PMID:
19461298
6.

Differential antagonism of endomorphin-1 and endomorphin-2 spinal antinociception by naloxonazine and 3-methoxynaltrexone.

Sakurada S, Hayashi T, Yuhki M, Fujimura T, Murayama K, Yonezawa A, Sakurada C, Takeshita M, Zadina JE, Kastin AJ, Sakurada T.

Brain Res. 2000 Oct 20;881(1):1-8.

PMID:
11033087
7.

3H-morphine-6beta-glucuronide binding in brain membranes and an MOR-1-transfected cell line.

Brown GP, Yang K, Ouerfelli O, Standifer KM, Byrd D, Pasternak GW.

J Pharmacol Exp Ther. 1997 Sep;282(3):1291-7.

8.

Heroin antinociception changed from mu to delta receptor in streptozotocin-treated mice.

Rady JJ, Gorny JM, Fujimoto JM.

Jpn J Pharmacol. 1998 Dec;78(4):443-54.

9.
11.

Morphine-6-O-beta-D-glucuronide but not morphine-3-O-beta-D-glucuronide binds to mu-, delta- and kappa- specific opioid binding sites in cerebral membranes.

Löser SV, Meyer J, Freudenthaler S, Sattler M, Desel C, Meineke I, Gundert-Remy U.

Naunyn Schmiedebergs Arch Pharmacol. 1996 Jul;354(2):192-7.

PMID:
8857597
12.
13.

No heroin or morphine 6beta-glucuronide analgesia in mu-opioid receptor knockout mice.

Kitanaka N, Sora I, Kinsey S, Zeng Z, Uhl GR.

Eur J Pharmacol. 1998 Aug 14;355(1):R1-3.

PMID:
9754945
14.

The effect of the irreversible mu-opioid receptor antagonist clocinnamox on morphine potency, receptor binding and receptor mRNA.

Chan K, Brodsky M, Davis T, Franklin S, Inturrisi CE, Yoburn BC.

Eur J Pharmacol. 1995 Dec 12;287(2):135-43.

PMID:
8749027
15.

Non-opioid induction of morphine-6-glucuronide synthesis is elicited by prolonged exposure of rat hepatocytes to heroin.

Graziani M, Antonilli L, Togna AR, Brusadin V, Viola S, Togna G, Badiani A, Nencini P.

Drug Alcohol Depend. 2008 Dec 1;98(3):179-84. doi: 10.1016/j.drugalcdep.2008.05.008. Epub 2008 Jul 1.

PMID:
18597954
16.

Morphine tolerance in mice changes response of heroin from mu to delta opioid receptors.

Rady JJ, Holmes BB, Portoghese PS, Fujimoto JM.

Proc Soc Exp Biol Med. 2000 Jun;224(2):93-101.

PMID:
10806416
17.

Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.

Burke TF, Woods JH, Lewis JW, Medzihradsky F.

J Pharmacol Exp Ther. 1994 Nov;271(2):715-21.

PMID:
7965787
18.

Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.

Wu HE, Sun HS, Darpolar M, Leitermann RJ, Kampine JP, Tseng LF.

J Pharmacol Exp Ther. 2003 Dec;307(3):1135-41. Epub 2003 Oct 13.

19.

Selective antagonism of opioid analgesia by a sigma system.

Chien CC, Pasternak GW.

J Pharmacol Exp Ther. 1994 Dec;271(3):1583-90.

PMID:
7996472
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk